PRESS RELEASE: The Francis Crick Institute and Axol Bioscience announce exclusive licensing agreement
The Francis Crick Institute has signed an agreement giving Axol…
News
Latest News:
axoCellsTM Cortical Inhibitory Interneuron Progenitors for in vitro co-culture
New Product Announcement: Cortical Inhibitory Interneuron ProgenitorsAxol Bioscience has announced…
Better models of human disease: human iPSC derived cells
Better models of human disease: human iPSC derived cellsThere’s a…
Products:
Human iPSC product news
axoCellsTM Cortical Inhibitory Interneurons
Cortical Inhibitory InterneuronsInterneurons are involved in major neurological disease types.…
Services:
News from our custom laboratory services
Transform in vitro assays with human iPSC-derived sensory neurons, mature in 21 days
Why are Axol’s human iPSC-derived sensory neurons transforming in vitro…
Company:
Axol company news
How our license with The Francis Crick Institute could de-risk drug development
How our license with The Francis Crick Institute could de-risk…
Events:
Conferences and events
Axol Team Leader presents at global ALS conference
Axol Team Leader presents at global ALS conference Stuart Prime,…
Case Studies:
Latest case studies and collaborations
The 3D Neuromuscular Junction in a Dish
Could this new assay made using human stem cells revolutionize ALS research?
Building The Nervous System – on a Chip
An interview with Thibault Honegger, CEO of NETRI
How can we investigate Alzheimer’s Disease progression without looking inside people’s heads?
Professor Selina Wray explains…
All Articles:
Axol Team Leader presents at global ALS conference
Axol Team Leader presents at global ALS conference Stuart Prime,…
How our license with The Francis Crick Institute could de-risk drug development
How our license with The Francis Crick Institute could de-risk…
axoCellsTM Cortical Inhibitory Interneurons
Cortical Inhibitory InterneuronsInterneurons are involved in major neurological disease types.…
